April 19, 2016 Mindy Goldstein will talk about anti-aging and IR - An anti-aging cream that expands sun care to help protect against infrared damage. The next generation of skincare.
Sheraton Stamford Hotel
700 E Main St
Stamford CT 06901
In the 1980’s, research lead to the finding that Infrared radiation (IR) may contribute to premature skin aging due to damage that it caused in the skin. Initially it was believed that IR would not penetrate the skin but it has since been shown that IRA, wavelengths 760-1440 nm, penetrates the skin as deeply as UVA. Continuing research has shown that the skin damage that IRA causes is similar to both UVA and UVB skin damage and it may actually increase the damage done by UVA and UVB radiation. There is some belief that IRA plays an important role in dermal inflammation, photoaging and cancer formation. Thus considering the mounting evidence on IR skin damage, suncare products that filter the UVA and UVB rays may be insufficient since they do not block all the damaging rays emitted from the sun. It would be in the consumer’s best interest to consider a new perspective on IR radiation and that protection from IR should be incorporated into modern suncare products. A number of In vitro, Ex vivo and In vivo methods have been used to look at the protection from the damaging effects of IR radiation. This presentation will look at the testing of an anti-aging formula that extends sun protection to include protection against infrared radition using a new In vivo assay. The results of the testing will show that it is possible to measure the erythema caused by infrared radiation and the statistically significant reduction in erythema by bio-active ingredients targeting the underlying damage caused by IR.
Dr. Goldstein received her B.S. with honors in Biochemistry, M.S. in Pathology and Ph.D. in Basic Medical Sciences from New York University in the area of UV and gamma radiation damage to DNA and DNA repair. She has been credited with more than eleven publications in scientific journals and books and has been awarded patents in the area of raw materials, encapsulation and controlled release. Dr. Goldstein has been in the cosmetic industry since 1987 and is currently consulting for companies within the personal care, pharmaceutical and nutraceutical industries. Most recently she was Vice President of Research & Development and Product Development for Atlantic Coast Media Group, Jersey City. Previously, Dr. Goldstein served as Executive Director, Research & Development, for The Estee Lauder Companies, Melville, NY. Her responsibilities included supplier contact for REACH activities, internal commercialization of new treatment actives for all of the Estee Lauder brands, troubleshooting formulation issues with active materials, encapsulation technology and identifying new platform technologies. She has also held Directors positions in R & D at Bath & Body Works, Lipo Chemicals and Collaborative Laboratories. She is an active member of the Society of Cosmetic Chemists and served as the Chair of the Long Island Chapter in 1994, the 1998 and 2009 Chair of the Committee on Scientific Affairs and the 2002 National President of the Society of Cosmetic Chemists. Dr. Goldstein was editor twice as well as a reviewer for the Journal of Cosmetic Science. She is a member of numerous professional and scientific organizations including the PCPC Nomenclature Committee where she is chair of the subcommittee on biotechnology, botanicals and ferments. Dr. Goldstein also serves as an advisor to Cosmetic and Toiletries magazine.
Registration 5:30 - 6:00pm
Register below or email Cynthia
SCC Members $45
Students and Unemployed $35